19-NOR-4.ALPHA.-(PYRIDINOYLHYDRAZINOCARBONYL)-16-(4-PYRIDINOYLHYDRAZONO)-ENT-BEYERANE
UNII L7VE8TCS9F

Substance Identification & Data

This profile provides standardized clinical and technical data for 19-nor-4.alpha.-(pyridinoylhydrazinocarbonyl)-16-(4-pyridinoylhydrazono)-ent-beyerane, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L7VE8TCS9F.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1334421-53-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L7VE8TCS9F

CAS Registry Number

1334421-53-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

19-NOR-4.ALPHA.-(PYRIDINOYLHYDRAZINOCARBONYL)-16-(4-PYRIDINOYLHYDRAZONO)-ENT-BEYERANE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C32H40N6O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XWSGUXSEOQINKI-OGKYUUCPSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

162368351

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@]12([C@@](CCC[C@]1([C@]3([C@@]4(C[C@](CC3)(\C(\C4)=N/NC(=O)c5ccncc5)C)CC2)[H])C)(C(NNC(c6ccncc6)=O)=O)C)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 19-nor-4.alpha.-(pyridinoylhydrazinocarbonyl)-16-(4-pyridinoylhydrazono)-ent-beyerane. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.